Pfizer Inc. (PFE)

Is your portfolio getting thinned out by all the profit-taking that tends to materialize when the market reaches record highs? That's OK.

Pfizer stock currently trades at very low volatility. That could mean it's ripe for a breakout trade, like a long strangle.

I remain bearish on Pfizer due to pricing pressures from IRA/340B and a looming 2026 patent cliff, despite Q2 2025 earnings beat. Cost-cutting measures have lifted EPS above expectations and could del...

Pfizer offers an attractive near-7% dividend yield, appealing for income-focused investors. Despite recent stagnation, Pfizer has consistently maintained its dividend payout and remains undervalued. T...

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and immuno...

What's better than a stock that pays great dividends? How about one that's also a bargain?

Pfizer's oncology portfolio, boosted by Seagen and strong drug sales, fuels Q2 growth and positions the company for future cancer treatment gains.

Finding a high-yielding stock that is safe to hang on to can be a rarity. When yields get high (e.g.

If you're looking to boost your passive income stream with dividend-paying stocks, there's a tough dilemma that we all face. Stocks that offer high yields generally do so because their dividend payout...

Dividend stocks are a great investment choice for many reasons. Buying on the dip is even better, provided, of course, they have the means to bounce back.